EXAWIZARDS

Less than 10% of the respondents used ChatGPT and other generative AIs on a daily basis;  More than 90% of the finance and insurance industry has used the system, while 30% of the manufacturing industry has not used it. ―ExaWizards conducted a questionnaire survey on the use of a generative AI to participants of its seminar supported by the Japan Business Federation to which 514 people from 274 companies responded―

SocioFuture Adopts “exaBase DX Assessment & Learning” Approx. 500 employees playing leading roles in operational reforms have started to receive e-learning training
―With ExaWizards’ support, SocioFuture identifies employees’ skills and abilities aiming to build an organizational structure where each department can voluntarily promote operational reforms utilizing DX by FY2025―

ExaWizards, ChatGPT Service for Enterprises “exaBase Generative AI powered by GPT-4″ Service Launched ~Security and compliance management included as standard features, 900 yen/month basic fee, accepting applications for a free trial~

ExaWizards and SANKEN, Osaka University Jointly Operationalizes Program Medical Device (SaMD) for Major Neurocognitive Disorder Diagnosis Support Basic agreement reached on exclusive development and marketing of AI applications based on patents for medical evaluation

“exaBase DX Assessment & Learning” : Releasing “DIA 3.0” Assessment Fully Compliant with Ministry of Economy, Trade and Industry’s “Digital Skill Standards” This Summer
“All-encompassing DX Talent Search and Training: Supporting Two Standards, DX Literacy Standards and DX Promotion Skill Standards”

ExaWizards Starts Accepting Reservations for a Beta Version of “exaBase IR Assistant powered by ChatGPT”
—ChatGPT-enabled efficient IR support, generating assumed questions and answers optimized for each company. Patent pending for the generative process visualization technology that realizes accuracy improvement by the user.

ExaWizards and Kyoto University Develop Drug Safety Evaluation AI Learning from PMDA Evaluation Results 〜Promote more efficient reporting and evaluation of pharmaceutical products and reduce the number of cases requiring human evaluation〜

ExaWizards Acquires a Patent for Anomaly Detection Technology Combining AI and Optics　-AI that detects foreign matter contamination or state changes not detectable with the human eye by recognizing the test object and optimizes the wavelengths of lights applied to it-

“exaBase Generative AI powered by GPT-4″ was featured in an article in NIKKEIxTREND

Director Ishiyama’s article on generative AI appeared in the Nikkei Business E-edition.

The Nikkei Business Daily published an article about Automatic Photo Service “Torinku”

Nikkei xTECH published an article about “exaBase IR Assistant powered by ChatGPT” and “exaBase Generative AI powered by GPT-4″

Nikkei Business published an article about “exaBase IR Assistant powered by ChatGPT”

Nikkei published an article about “exaBase IR Assistant powered by ChatGPT”

Listed in “100 Startups with a Track Record of Collaboration with Government” by the Ministry of Economy, Trade and Industry.

The Nikkei Business Daily reports on collaboration with PERSOL Holdings

【Event】ExaWizards Care & Med Tech Forum 2023 〜Pioneering the next generation of medical healthcare and industrial innovation with AI〜

[Case Study] Sumitomo Pharma：Introduction of “exaBase FAQ,” an AI chatbot, reduces approximately 90% of routine work inquiries and improves productivity of MRs

Notice of Decision Regarding the Repurchase of Own Shares

【Event】Automation and Autonomy of Crew Work at Space Station – Explanation of Initiatives Using Imitation Learning and Predictive Learning Technologies

A dialogue Professor Michael Osborne, and the Japan Post Group published

AI Software Integrated Development Environment “exaBase Studio” Page now Available

Company Announcements

ExaWizards Academia Special Event “Gen-Z Entrepreneurs Challenging to Solve Social Issues with Technology” will be hold in May